TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34330848

Group type: EXPERIMENTAL
Intervention: Intention-to-treat (ITT) analysis
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Modified ITT analysis
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Non-ITT analysis
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Participants completing the trial for primary outcome
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Participants included in analysis for primary outcome
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Missing primary outcome data >20%
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Missing primary outcome data 10%-20%
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Reporting of missing data handling
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Sensitivity analysis utilization
Number of subjects: 160
Study: 32690508

Group type: EXPERIMENTAL
Intervention: SPOON behavioural change strategy and SQ-LNS
Number of subjects: 1628

Group type: EXPERIMENTAL
Intervention: SPOON behavioural change strategy and micronutrient powders
Number of subjects: 1628

Group type: COMPARATOR
Intervention: Standard of care provided by the Ministry of Health (micronutrient powders)
Number of subjects: 1628
Study: 35073865

Group type: EXPERIMENTAL
Intervention: CHAPS intervention (nurse-led care management program)
Number of subjects: 140
Study: 32071367

Group type: EXPERIMENTAL
Intervention: Individualized plus optimized nutrition (experimental)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Optimized nutrition alone (controls)
Number of subjects: 120
Study: 35289043

Group type: EXPERIMENTAL
Intervention: Topical latanoprost 0.005% solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32145111

Group type: EXPERIMENTAL
Intervention: ixazomib-lenalidomide-dexamethasone (IRd)
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo-lenalidomide-dexamethasone (placebo-Rd)
Number of subjects: 0
Study: 32568601

Group type: EXPERIMENTAL
Intervention: Weekend physical therapy services in the sub-acute setting (Phase 2, n = 130)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Weekend physical therapy services in the acute setting (Phase 1, n = 117)
Number of subjects: 247
Study: 33913511

Group type: EXPERIMENTAL
Intervention: secukinumab 300 mg via subcutaneous injection at baseline, week 1-4, and then every 4 weeks until week 48
Number of subjects: 853

Group type: COMPARATOR
Intervention: adalimumab 40 mg via subcutaneous injection every 2 weeks from baseline until week 50
Number of subjects: 853

Group type: EXPERIMENTAL
Intervention: secukinumab 300 mg
Number of subjects: 853

Group type: COMPARATOR
Intervention: adalimumab 40 mg
Number of subjects: 853
Study: 34216334

Group type: EXPERIMENTAL
Intervention: Recent incarceration (within the past three months)
Number of subjects: 1482

Group type: COMPARATOR
Intervention: Never incarcerated or previously incarcerated but not in the past three months
Number of subjects: 1482
Study: 33913217

Group type: EXPERIMENTAL
Intervention: Psychological nursing and health education
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 84
Study: 32730096

Group type: EXPERIMENTAL
Intervention: Pivotal Response Treatment
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Robot-assisted Pivotal Response Treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: Both treatment groups
Number of subjects: 44
Study: 35596774

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) 600 mg once daily for 6 months
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 34585747

Group type: EXPERIMENTAL
Intervention: Residual AUD symptoms (1 vs. no symptoms) at 6 months
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: AUD remission
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Failed reduction/cessation of alcohol use
Number of subjects: 323
Study: 34371209

Group type: COMPARATOR
Intervention: anodal tDCS
Number of subjects: 150

Group type: COMPARATOR
Intervention: high-frequency tRNS + DC-offset
Number of subjects: 150

Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 150
Study: 33008395

Group type: EXPERIMENTAL
Intervention: Genetically increased Blautia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elevated γ‐aminobutyric acid (GABA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically increased Enterobacteriaceae family
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically increased Gammaproteobacteria class
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gut production of serotonin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically increased Bacilli class
Number of subjects: 0
Study: 34920155

Group type: COMPARATOR
Intervention: 0.05% sodium fluoride (F, positive control)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 150 mM calcium lactate solution followed by 0.05% sodium fluoride solution (Ca→F)
Number of subjects: 22

Group type: COMPARATOR
Intervention: 150 mM calcium lactate solution premixed with 0.05% sodium fluoride solution (CaF2, active control)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Deionized water (negative control)
Number of subjects: 22
Study: 32744373

Group type: EXPERIMENTAL
Intervention: Nurse-coordinated hospital-initiated transitional care programme for 6 months
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Nurse-coordinated hospital-initiated transitional care programme
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control group (no transitional care programme)
Number of subjects: 270
Study: 33827659

Group type: EXPERIMENTAL
Intervention: Comprehensive pre‐pregnancy lifestyle intervention to promote weight loss with ongoing treatment until conception
Number of subjects: 252

Group type: COMPARATOR
Intervention: Educational control group
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Comprehensive pre‐pregnancy lifestyle intervention
Number of subjects: 252
Study: 32553151

Group type: EXPERIMENTAL
Intervention: IONIS-DGAT2Rx (250 mg, once weekly for 13 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: IONIS-DGAT2Rx
Number of subjects: 44
Study: 33836158

Group type: EXPERIMENTAL
Intervention: Chlorhexidine plus alcohol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Povidone iodine plus alcohol
Number of subjects: 0
Study: 34060185

Group type: EXPERIMENTAL
Intervention: computerised speechreading training for three weeks
Number of subjects: 92

Group type: COMPARATOR
Intervention: business‐as‐usual controls
Number of subjects: 92
Study: 33211592

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low dose (4.03 mmol) of inorganic nitrate
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High dose (8.06 mmol) of inorganic nitrate
Number of subjects: 14
Study: 35440710

Group type: EXPERIMENTAL
Intervention: Head Start
Number of subjects: 4442
Study: 33443699

Group type: EXPERIMENTAL
Intervention: Remote monitoring after discharge
Number of subjects: 409

Group type: COMPARATOR
Intervention: Not referred for remote monitoring
Number of subjects: 409
Study: 32936675

Group type: EXPERIMENTAL
Intervention: Intervention A: Requiring ICU clinicians to document a functional prognostic estimate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention B: Providing justification if not offering comfort-focused care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined interventions A + B
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study: 35329415

Group type: EXPERIMENTAL
Intervention: Breathing Exercises (BE)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Yoga (Y)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Pilates (P)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Interval-Training (IT)
Number of subjects: 61
Study: 34819434

Group type: EXPERIMENTAL
Intervention: Operative treatment (open reduction and internal fixation using tension band wiring)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-operative treatment (boot cast)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 34
Study: 32845968

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 1089
Study: 36055813

Group type: EXPERIMENTAL
Intervention: gemcitabine/adavosertib (arm A)
Number of subjects: 55

Group type: COMPARATOR
Intervention: gemcitabine/placebo (arm B)
Number of subjects: 55
Study: 33817992

Group type: EXPERIMENTAL
Intervention: 75% N2O
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 50% N2O
Number of subjects: 65

Group type: COMPARATOR
Intervention: 0% N2O
Number of subjects: 65
Study: 32093664

Group type: EXPERIMENTAL
Intervention: Nurse care coordination program
Number of subjects: 3007
Study: 34914868

Group type: EXPERIMENTAL
Intervention: Molnupiravir (800 mg twice daily for 5 days)
Number of subjects: 1433

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1433

Group type: EXPERIMENTAL
Intervention: Molnupiravir
Number of subjects: 1433
Study: 33295137

Group type: EXPERIMENTAL
Intervention: Tricalcium phosphate with or without hyaluronic acid (HA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Anorganic bovine bone mineral
Number of subjects: 24
Study: 32417533

Group type: EXPERIMENTAL
Intervention: Task-activated CBFv from 69 healthy participants for five cognitive tasks (attention, verbal fluency, language, visuospatial, memory)
Number of subjects: 135
Study: 35962311

Group type: EXPERIMENTAL
Intervention: Ice water injection (250 ml) toward the duodenal papilla at the end of ERCP
Number of subjects: 440

Group type: COMPARATOR
Intervention: Control group (no ice water injection)
Number of subjects: 440
Study: 33258566

Group type: EXPERIMENTAL
Intervention: Oversized stent (oversized by 10% according to mean lumen diameter)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Non-oversized stent (control group)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Both groups (oversized and non-oversized)
Number of subjects: 122
Study: 33136077

Group type: EXPERIMENTAL
Intervention: Real contra‐lesion low frequency repetitive transcranial magnetic stimulation (LF‐rTMS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham contra‐lesion low frequency repetitive transcranial magnetic stimulation (LF‐rTMS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Physical therapy program for the upper limb
Number of subjects: 40
Study: 35364115

Group type: EXPERIMENTAL
Intervention: Best-Worst Scaling (BWS) survey
Number of subjects: 300
Study: 32914852

Group type: EXPERIMENTAL
Intervention: Family-based behavioral obesity treatment (FBT) for 4 months
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Weight maintenance interventions for 8 months
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Latent profiles of general psychopathology (GP) and eating disorder psychopathology (EDP)
Number of subjects: 172
Study: 36154912

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Subcostal transversus abdominis plane block (TAPB)
Number of subjects: 60
Study: 34391248

Group type: EXPERIMENTAL
Intervention: Pilates exercise (8-week group-supervised, mat-based program)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Usual pharmacologic and rehabilitation standard of care (control group)
Number of subjects: 39
Study: 32711878

Group type: EXPERIMENTAL
Intervention: Heterologous bone graft and nanohydroxyapatite (NHA)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Pure graft (heterologous bone graft only)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups (Group A and Group B)
Number of subjects: 26
Study: 35609671

Group type: EXPERIMENTAL
Intervention: Escitalopram (up to 20 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Exercise (3 times/wk)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 120
Study: 33047944

Group type: EXPERIMENTAL
Intervention: Cervical proprioception exercises
Number of subjects: 42

Group type: COMPARATOR
Intervention: Cervical mobility exercises
Number of subjects: 42
Study: 32686487

Group type: EXPERIMENTAL
Intervention: Experimental treatment (testing, in-person feedback, and two calls from a care-coordinator)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard-care treatment (neuropsychological testing and phone feedback)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and standard-care)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Experimental treatment and Standard-care treatment
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard-care treatment
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Experimental treatment
Number of subjects: 49
Study: 36498425

Group type: EXPERIMENTAL
Intervention: Practicing acts of kindness
Number of subjects: 122

Group type: COMPARATOR
Intervention: Neutral intervention (practicing acts related to studying)
Number of subjects: 122
Study: 35847566

Group type: EXPERIMENTAL
Intervention: B-OPAT (Buprenorphine plus OPAT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 90
Study: 33255807

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (150,000 IU)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both groups (Vitamin D3 and Placebo)
Number of subjects: 27
Study: 33769666

Group type: EXPERIMENTAL
Intervention: High-protein/low-carbohydrate diet (HPD)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Mediterranean/low glycaemic index diet (MED)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Reference diet (REF)
Number of subjects: 15
Study: 32975159

Group type: EXPERIMENTAL
Intervention: Housing First intervention (community-based scattered-site housing and support services)
Number of subjects: 575

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 575
Study: 35963048

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 0
Study: 34164929

Group type: EXPERIMENTAL
Intervention: Persistent elevated depressive symptom trajectory
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Elevated depressive symptoms
Number of subjects: 179
Study: 34657367

Group type: EXPERIMENTAL
Intervention: Robot-assisted radical cystectomy with intracorporeal urinary diversion (iRARC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 33593341

Group type: COMPARATOR
Intervention: Passive physical treatment
Number of subjects: 9328

Group type: COMPARATOR
Intervention: Psychological treatment
Number of subjects: 9328

Group type: COMPARATOR
Intervention: Active physical treatment
Number of subjects: 9328
Study: 33608106

Group type: EXPERIMENTAL
Intervention: Conventional cigarette smoke (Marlboro Medium; Philip Morris)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Heated tobacco product smoke (IQOS 2.4 plus holder, Marlboro Heets Silver; Philip Morris)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (exposed to air)
Number of subjects: 90
Study: 33109246

Group type: EXPERIMENTAL
Intervention: favipiravir with interferon beta‐1a
Number of subjects: 60

Group type: COMPARATOR
Intervention: lopinavir/ritonavir with interferon beta‐1a
Number of subjects: 60
Study: 33706065

Group type: EXPERIMENTAL
Intervention: Topical ozonated oil, applied twice a day for 60 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (non-ozonated oil), applied twice a day for 60 days
Number of subjects: 80
Study: 32892758

Group type: EXPERIMENTAL
Intervention: Imagery rescripting (ImRs)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Eye movement desensitisation and reprocessing (EMDR)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Imagery rescripting (ImRs) and Eye movement desensitisation and reprocessing (EMDR)
Number of subjects: 155
Study: 32247284

Group type: EXPERIMENTAL
Intervention: Bayesian nonparametric approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Data from a brain cancer trial
Number of subjects: 0
Study: 34099023

Group type: EXPERIMENTAL
Intervention: Acupuncture intervention (30 min, 2–3 times/week for 12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham control acupuncture intervention (30 min, 2–3 times/week for 12 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acupuncture intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham control acupuncture intervention
Number of subjects: 60
Study: 32145293

Group type: EXPERIMENTAL
Intervention: Water-based continuous training (CTG; n=21)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Water-based interval training (ITG; n=20)
Number of subjects: 41
Study: 33952378

Group type: EXPERIMENTAL
Intervention: Palliative care interventions addressing quality delivery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collaboration among health institutions for palliative care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Policies and programs for palliative care
Number of subjects: 0
Study: 34260969

Group type: EXPERIMENTAL
Intervention: CRTpowerdist package
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Simulations and analytic formulae
Number of subjects: 20
Study: 35405482

Group type: EXPERIMENTAL
Intervention: High-intensity intermittent exercise (HIIE) session (10 x 1-min sprints with 1 min of rest) at 90% of their maximum aerobic velocity (MAV)
Number of subjects: 14
Study: 33770365

Group type: EXPERIMENTAL
Intervention: Daratumumab in combination with bortezomib, melphalan, and prednisone (D-VMP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: VMP (bortezomib, melphalan, and prednisone)
Number of subjects: 0
Study: 32035692

Group type: EXPERIMENTAL
Intervention: Standard chemoradiation combined with recombinant human endostatin injection (Endostar)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Standard chemoradiation
Number of subjects: 114
Study: 33278235

Group type: EXPERIMENTAL
Intervention: Eyedrops (phenylephrine, tropicamide, fluorescein‐proparacaine)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometry (GAT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (contralateral eye measurements)
Number of subjects: 62
Study: 32425051

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 300

Group type: COMPARATOR
Intervention: Azithromycin
Number of subjects: 300
Study: 35109763

Group type: EXPERIMENTAL
Intervention: 100 mg vitamin B6 daily
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 34044341

Group type: EXPERIMENTAL
Intervention: Blended case-centred learning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Offline case-centred learning
Number of subjects: 0
Study: 33211728

Group type: EXPERIMENTAL
Intervention: C-MAC® Video-Stylet (VS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: C-MAC Macintosh video laryngoscope (VL)
Number of subjects: 21
Study: 35859471

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 27

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 27
Study: 32791945

Group type: EXPERIMENTAL
Intervention: Robot-assisted arm training with WAM (RAT-WAM)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Robot-assisted arm training with Proficio (RAT-P)
Number of subjects: 40
Study: 36130313

Group type: EXPERIMENTAL
Intervention: Standard Group
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Enhanced Group
Number of subjects: 403

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 403
Study: 37589610

Group type: EXPERIMENTAL
Intervention: Patient-activation tool for intensification of medications for chronic heart failure
Number of subjects: 292
Study: 33073594

Group type: EXPERIMENTAL
Intervention: Graphic risk messages
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Risk education messages
Number of subjects: 601

Group type: COMPARATOR
Intervention: Instagram ads alone
Number of subjects: 601
Study: 32739670

Group type: EXPERIMENTAL
Intervention: Transitional care intervention including risk assessment for early readmission, health education from admission to predischarge, individualized discharge planning, and weekly telephone follow-up for one month and WeChat follow-up postdischarge.
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Transitional care intervention
Number of subjects: 220

Group type: COMPARATOR
Intervention: Routine care of comparable length and follow-up contact
Number of subjects: 220
Study: 35177070

Group type: EXPERIMENTAL
Intervention: Intervention stores with modified availability, accessibility, and promotion of fruits and vegetables, including a customer-directed marketing campaign for 6 months.
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Intervention stores
Number of subjects: 369

Group type: COMPARATOR
Intervention: Control stores
Number of subjects: 369
Study: 34029936

Group type: EXPERIMENTAL
Intervention: Manual diaphragmatic stretching technique (MDST) alongside standard physiotherapy (SDPT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard physiotherapy (SDPT)
Number of subjects: 53
Study: 32994020

Group type: EXPERIMENTAL
Intervention: Resveratrol/ethanol 10 mg/mL
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (0 mg/mL resveratrol/ethanol)
Number of subjects: 64
Study: 35691791

Group type: EXPERIMENTAL
Intervention: Intranasal gonadorelin treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no gonadorelin treatment)
Number of subjects: 36
Study: 33482396

Group type: EXPERIMENTAL
Intervention: Targeted mailings
Number of subjects: 874

Group type: COMPARATOR
Intervention: Brochure/flyer
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Recruitment methods
Number of subjects: 874
Study: 32622768

Group type: EXPERIMENTAL
Intervention: Novel penile splint (Early Traction Therapy - ETT) applied post-surgery
Number of subjects: 46